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Abstract 
Introduction: One of the limitations reported with cardiotocography (CTG) is the modest 
interobserver agreement observed in tracing interpretation. This study compared agreement, 
reliability and accuracy of CTG interpretation using the FIGO, ACOG and NICE guidelines. 
Material and methods: A total of 151 tracings was evaluated by 27 clinicians from three 
centers where FIGO, ACOG and NICE guidelines were routinely used. Interobserver 
agreement was evaluated using the proportions of agreement (PA) and reliability with the 
kappa (k) statistic. The accuracy of tracings classified as “pathological/category III” was 
assessed for prediction of newborn acidemia. For all measures, 95% confidence intervals 
(95%CI) were calculated. Results: CTG classifications were more distributed with FIGO 
(9%, 52%, 39%) and NICE (30%, 33%, 37%) than with ACOG (13%, 81%, 6%). The 
category with the highest agreement was ACOG category II (PA=0.73 95%CI 0.70-76), and 
the ones with the lowest agreement were ACOG categories I and III. Reliability was 
significantly higher with FIGO (k=0.37, 95%CI 0.31-0.43), and NICE (k=0.33, 95%CI 0.28-
0.39) than with ACOG (k= 0.15, 95%CI 0.10-0.21), however all represent only slight/fair 
reliability. FIGO and NICE showed a trend towards higher sensitivities in prediction of 
newborn acidemia (89% and 97% respectively) than ACOG (32%,), but the latter achieved a 
significantly higher specificity (95%). Conclusions: With ACOG guidelines there is high 
agreement in category II, low reliability, low sensitivity and high specificity in prediction of 
acidemia. With FIGO and NICE guidelines there is higher reliability, a trend towards higher 
sensitivity, and lower specificity in prediction of acidemia. 
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Key message 
Agreement, reliability and accuracy of cardiotocography interpretation using the FIGO, 
ACOG and NICE guidelines are compared. The study demonstrates significant differences 
between these three major classification systems that are important for the development of 
future guidelines.  
 
Abbreviations 
ACOG - American College of Obstetrics and Gynecology 
CTG - cardiotocography 
FHR - fetal heart rate 
FIGO - International Federation of Gynecology and Obstetrics 
NICE - National Institute of Health and Clinical Excellence 
PA - proportions of agreement  
 
 
Introduction 
 
Cardiotocography (CTG) is an integral part of intrapartum care in most high-income 
countries. However, one of its limitations is the modest interobserver agreement in CTG 
interpretation (1–5). The International Federation of Gynecology and Obstetrics (FIGO) 
published its first guidelines on fetal heart rate (FHR) monitoring in 1987 (6) and established 
the only international consensus available at the time the present study was undertaken. Many 
national scientific organizations have also published guidelines on the subject, but perhaps 
those with the largest impact were developed by the American College of Obstetricians and 
Gynecologists (ACOG) and the United Kingdom National Institute of Clinical Excellence 
(NICE). ACOG has published several revised versions of their original publication in 1974 
(7), the last of which in 2010 in association with the National Institute of Child Health and 
Human Development and the Society for Maternal-Fetal Medicine (8). The Royal College of 
Obstetricians and Gynaecologists published its first guidelines in 2001, and updated them in 
2007 in association with NICE (9).
 
This was the latest version available at the time the 
present study was undertaken. 
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 These three guidelines have important differences, not only in the definition of 
individual CTG features but also in the criteria used for overall tracing classification (tables 1 
and 2)(10). The aim of this study was to compare interobserver agreement, reliability and 
accuracy of CTG analysis, when performed according to the FIGO, ACOG and NICE 
guidelines. The hypothesis was that the differences in guideline structure, as well as in clarity 
and complexity of definitions, could result in different interobserver agreements, and in 
different predictive capacities for CTG interpretation. A second hypothesis was that observer 
experience would have an additional impact on these findings. 
 
Material and methods 
 Cases were selected from a pre-existing database of intrapartum CTGs acquired in a 
tertiary-care university hospital (11). All patients gave their written informed consent for 
their tracings to be used in an anonymous way for research purposes. Laboring women were 
consecutively selected if they fulfilled the following inclusion criteria: singleton pregnancy, ≥ 
37 gestational weeks, fetus in cephalic presentation, absence of known fetal malformations, 
active phase of labor and an established indication for continuous CTG monitoring 
(augmented or induced labor, meconium staining of the amniotic fluid, abnormalities 
detected on admission CTG or on intermittent fetal auscultation). All patients were 
continuously monitored until delivery, using a fetal electrode and an external 
tocodynamometer.  
 
Paired umbilical cord blood sampling and analysis was performed in all cases, and 
fetal acidemia was defined as an umbilical artery pH value of 7.05 or less. Cases were 
subsequently excluded if one of the following situations was documented: total tracing length 
less than 60 minutes, signal loss in the last hour of the tracing exceeding 15%, interval 
between tracing-end and vaginal birth exceeding 5 minutes, or interval between tracing-end 
and cesarean birth exceeding 20 minutes, complications with the potential to influence fetal 
oxygenation recorded between tracing-end and delivery (shoulder dystocia, difficult cesarean 
extraction, etc), anesthetic complications at the time of delivery, or invalid cord blood gas 
values (11).  
 
A total of 193 patients were enrolled and 42 were subsequently excluded, leaving 151 
cases for analysis in the study. Only the last 60 minutes of patients’ tracings obtained before 
delivery were presented to clinicians. No additional clinical information was provided, except 
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that records were acquired just before birth in singleton term pregnancies. CTG tracings were 
presented at a paper speed of 1 cm/ min to the group of clinicians using the FIGO and NICE 
guidelines and at a paper speed of 3 cm/min to the group of clinicians using the ACOG 
guidelines.  
 
A total of 27 clinicians performed the analysis of CTGs, nine from each of three 
different centers where the referred guidelines were routinely used. The FIGO guidelines 
group were recruited from the Santa Maria Hospital in Lisbon, Portugal, the ACOG 
guidelines group from the Beth Israel Deaconess Medical Centre in Boston, USA, and the 
NICE guidelines group from St. George’s Hospital - University of London, UK. At each 
center, three of the selected clinicians had more than 10 years of experience in CTG analysis, 
three had six to10 years of experience, and three had less than six years of experience. Each 
clinician only evaluated the 151 tracings once. and according to the guidelines he/she was 
accustomed to. 
 
 Clinicians received digital copies of the tracings by email in Word format, together 
with a file summarizing the main points of the guidelines to be used. They were asked to 
view the tracings independently and to evaluate FHR baseline, variability, accelerations and 
decelerations, before attributing an overall tracing classification. 
 
Statistical analyses 
Interobserver agreement was assessed using the proportions of agreement (PA) and 
the proportion of specific agreement (PA for each category), as recommended by the 
“Guidelines for reporting reliability and agreement studies” (GRRAS) (12). For all results, 
95% confidence intervals were calculated, and findings were considered significantly 
different if these intervals did not overlap. If the lower limit of the 95% confidence intervals 
for PA was under 0.50, agreement was also considered to be poor (13). Reliability was 
evaluated with the kappa statistic (k-Light’s kappa for n raters), which adjusts PA to the 
agreement expected by chance, so the distribution of ratings in the different classes 
influences the results. It is possible to obtain a high PA and a low kappa when the prevalence 
of a given rating is very high or low (14). Kappa values below 0.20 were considered as slight 
reliability; those ranging between 0.21 and 0.40 as fair reliability, those between 0.41 and 
0.60 as moderate reliability, those between 0.61 and 0.80 as substantial reliability, and values 
larger than 0.80 as almost perfect reliability (15). Tracings classified as pathological/category 
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III were compared with all the others regarding their capacity to predict newborn acidemia. 
Sensitivity and specificity were calculated with 95% of confidence intervals. Statistical 
analysis was performed using the R package obs.agree version 1.0 (Free Software 
Foundation, Boston, USA). 
 
Approval by the S. João Hospital, Porto Medical School Research Ethics Committee 
was obtained for the study (Comissão de Ėtica do Centro Hospitalar de São João, Parecer N ° 
28/2010, 19/07/2010). Procedures were in accordance with the ethical standards of the 
committee and with the Helsinki Declaration. 
 
Results 
All tracings were analyzed by the 27 clinicians, for a total of 4077 evaluations. Table 
3 displays the evaluation of basic CTG features and overall tracing classification by clinicians 
in each study group. In all groups, the majority of tracings were evaluated as having normal 
baseline and normal variability. Clinicians in the FIGO and ACOG groups considered that 
most tracings had accelerations, while those in the NICE group considered the opposite. All 
groups identified decelerations in the majority of tracings. The ACOG group classified 81% 
of tracings as category II, while the suspicious classification was only selected by 52% in the 
FIGO group and 33% in the NICE group. 
 
Interobserver agreement and reliability in evaluation of basic CTG features and 
overall tracing classification are displayed in table 4. For FHR baseline, agreement and 
reliability were high and similar in all groups. The highest agreement was achieved in 
identification of a normal FHR baseline, and results were significantly better in the ACOG 
and NICE groups than in the FIGO group. Bradycardia showed the lowest agreement, and no 
differences between the groups were identified.  
 
A high agreement was found in the evaluation of variability, with no significant 
differences occurring between the groups. All groups showed the highest agreement in 
identification of normal variability.  
 For identification of accelerations, a similar agreement was found between all groups, 
with the NICE group showing a significantly higher agreement in identification of “no 
accelerations”.  
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The FIGO group had a higher agreement than ACOG in identification of 
decelerations (both present and absent), and all groups showed a poorer agreement in 
identification of absent decelerations. 
 
In overall tracing classification, the ACOG group had a significantly higher 
agreement than FIGO, and both had a significantly higher agreement than NICE. While in the 
ACOG group category II classification reached a significantly higher agreement than any 
other guideline classification, category I and category III obtained a significantly lower 
agreement than others. A significantly lower reliability was obtained with the ACOG 
classification than with FIGO or NICE. Kappa values in overall tracing classification, 
represent a slight/fair reliability with all guidelines. 
 
Table 5 displays interobserver agreement according to the number of years of 
experience in CTG analysis. Clinicians with less than six years of experience in the ACOG 
group showed the highest agreement in tracing classification, but this was mainly due to 
agreement on category II. In the FIGO and NICE groups there were no significant differences 
in agreement, according to the level of experience. 
 
In the 151 cases evaluated there were seven newborns with an umbilical artery blood 
pH ≤ 7.05, but no cases of hypoxic-ischemic encephalopathy. The sensitivity and specificity 
of category III/ pathological tracings in prediction of acidemia is displayed in table 6. The 
FIGO and NICE groups showed a trend towards a higher sensitivity than ACOG, but the 
differences were not statistically significant. On the other hand, the ACOG group showed a 
significantly higher specificity than the others. No significant differences were found in these 
comparisons between levels of expertise. 
 
Discussion 
 This study compares the agreement, reliability and accuracy of FIGO, ACOG and 
NICE guidelines for CTG interpretation and showed that attribution of category II is very 
frequent with the ACOG guidelines, leading to a high overall interobserver agreement, a low 
reliability, a low sensitivity and a high specificity of category III tracings in prediction of 
fetal acidemia. With the FIGO and NICE guidelines, a more balanced distribution of 
classifications is seen, and there appears to be a higher sensitivity and a lower specificity of 
pathological tracings in prediction of fetal acidemia.  
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This study also confirms that there is high agreement in identification of normal 
baseline, tachycardia, normal variability, presence of accelerations and decelerations. It was 
not possible to evaluate the classification of decelerations, as these events are defined 
differently in the three guidelines.  
 
Other studies evaluating the reproducibility of CTG analysis using the FIGO and 
ACOG guidelines have shown that there is a fair to good agreement in evaluation of the 
baseline and accelerations, and a poor agreement regarding decelerations (3,16).
 
 It has also 
been reported that CTG classification as category I/normal is more reproducible than the 
other categories (4,5,17–19). Our study demonstrates that this depends on the selected 
guidelines. With the ACOG guidelines, classification in category I it was less reproducible, 
while with the other guidelines differences were usually small and not statistically significant.  
 
Three-tiered classification systems usually suggest no action for category I/normal 
tracings and rapid intervention for category III/pathological tracings. Thus, these two 
categories are probably the ones more directly associated with outcomes and interventions 
rates. A low percentage of tracings considered normal may be associated with higher rate of 
obstetric intervention, while a low percentage of tracings considered pathological may be 
associated with poor neonatal outcomes. Category II/suspicious includes a broad spectrum of 
heterogeneous FHR patterns that are inconsistently associated with fetal acidemia, making 
clinical management of these situations more uncertain. 
 
Several studies have shown that CTG has a high sensitivity and a limited specificity 
in the prediction of fetal hypoxia/acidosis. Our study demonstrates that this finding depends 
on the interpretation guidelines used. The ACOG guidelines tended to classify abnormal 
patterns more in category II, because of more restrictive criteria for category III, and some 
acidemia cases were classified in category II, hence the tendency for a lower sensitivity and 
higher specificity of these guidelines. With the FIGO and NICE guidelines acidemia cases 
were more in the pathological category, thereby increasing sensitivity for the detection of 
acidemia but decreasing specificity. These results, however, need to be interpreted with 
caution, given the low number of cases with newborn acidemia.  
 
 
A
cc
ep
te
d 
A
rt
ic
le
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Interobserver agreement and accuracy were not majorly affected by clinicians’ years 
of practice for FIGO and NICE groups, suggesting that they can be generalized to all 
clinicians with at least 6 years of experience. Similar findings have also been reported by 
others (16,19–22). On the other hand, clinicians with less years of experience may follow the 
guidelines more strictly and this may be responsible for the slightly better agreement obtained 
in the ACOG group. 
 
 The main strengths of the study are that it involved a large number of clinicians 
working in different centers where the CTG guidelines were routinely used, with paper 
speeds they were accustomed to. The selection of different years of clinical experience also 
contributes to a greater generalizability of results. In selection of tracings, only cases 
monitored until very close to birth were included, so that umbilical artery pH would closely 
reflect fetal hypoxia/acidosis occurring during the last minutes of labor. 
 
The number of cases selected for analysis was decided somewhat empirically, taking 
into account the expected capacity of observers to complete the task within a reasonable time 
period, and given the modest number of cases with acidemia in this sequentially selected 
population, it resulted in large confidence intervals for the sensitivity analysis. Tracing 
analysis was carried out at leisure, with immediate access to the guidelines, and the full 60-
minute tracings were made available. These conditions are very different from daily practice, 
where time pressure, memory recall of the guidelines, and frequent re-evaluation of ongoing 
tracings are the norm. The immediate availability of guidelines removes the memory issues 
that may be involved in tracing interpretation and focuses more on clinicians’ capacity to 
identify patterns and to follow guidance. 
 
Centers were selected because they used the referred guidelines in routine clinical 
practice, but the possibility of local or even individual adaptation of the guidelines cannot be 
ruled out, as well as the effect of local training and audit. All centers carry out regular CTG 
training, but course frequencies and methodologies are different. Local culture may for 
instance have been responsible for the decreased number of accelerations identified in the 
NICE guideline group, as the more rounded increases in FHR occurring after decelerations 
were most likely considered “shoulders” and not “true” accelerations. The last 60 minutes of 
the tracing were evaluated, as similar periods are commonly used for tracing classification, 
but the initial part may have been different from the end, and clinicians may have evaluated 
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this in different ways. The period before birth is usually the most challenging for CTG 
interpretation, and agreement could have been different in a more stable period of labor. To 
ensure a reasonable signal quality, internal FHR monitoring was used in all cases, but again a 
different agreement could have been achieved with external monitoring and greater signal 
loss. The sequential selection of cases with subsequent exclusion criteria guarantees the 
generalizability of results to a population that has good signal quality tracings and no 
unmonitored hypoxic events, but this does not occur in all intrapartum cases. It also resulted 
in a low number of cases with newborn acidemia, with consequences on the robustness of the 
accuracy analysis.  
 
 This study shows that there are important differences in the way clinicians interpret 
CTG tracings, depending on the guidelines they use. Differences in guideline structure, as 
well as in clarity and complexity of definitions, have a profound effect on interobserver 
agreement and reliability, as well as on the sensitivity and specificity of CTG classifications 
in predicting acidemia. These aspects need to be taken into consideration in the development 
of new guidelines. 
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Table 1. Comparison of the basic fetal heart rate (FHR) definitions contained in the International Federation of 
Gynecology and Obstetrics (FIGO) guidelines of 1987, the American College of Obstetricians and 
Gynecologists (ACOG) guidelines of 2010 and the National Institute of Clinical Excellence (NICE) guidelines 
of 2007. 
BASELINE FIGO Baseline FHR is the mean level of the FHR when this is stable, accelerations and decelerations being absent. It is determined over a time period 
of 5 or 10 min and expressed in bpm. 
 NICE Mean level of the FHR when this stable, excluding accelerations and decelerations. It is determined over a time period of 5 or 10 minutes and 
expressed in bpm 
 ACOG Mean FHR rounded to increments of 5 bpm during a 10-minute segment, excluding: periodic or episodic changes, periods of marked FHR 
variability, segments of baseline that differ > 25 bpm 
Normal baseline FIGO 110-150 bpm 
NICE 110-160 bpm 
ACOG 110-160 bpm 
Tachycardia FIGO (no definition) 
NICE >180 bpm (161-180 bpm is moderate tachycardia) 
ACOG >160 bpm 
Bradycardia FIGO < 80 bpm 
NICE <100 bpm (100-109 bpm is moderate bradycardia) 
ACOG <110 bpm 
VARIABILITY FIGO Oscillations of FHR around its mean level (long-term variability). This is usually only quantitated by description of the amplitude of the 
oscillations around the baseline heart rate.  
 NICE The minor fluctuations in baseline FHR occurring at three to five cycles per minute. It is measured by estimating the difference in bpm between 
the highest peak and lowest trough of fluctuation in a one-minute segment of the trace 
 ACOG Fluctuations in the baseline FHR that are irregular in amplitude and frequency. It is visually quantitated as the amplitude of peak-to-through in 
bpm. 
Normal variability FIGO Between 5-25 bpm 
NICE Greater than or equal to 5 bpm between contractions  
ACOG Amplitude range 6-25 bpm (moderate variability) 
Reduced 
variability 
FIGO < 5 bpm for more than 40 minutes (suspicious if variability 5-10 bpm for more than 40 minutes) 
NICE Less than 5 bpm for 40-90 minutes (non-reassuring) or >90 minutes (abnormal variability) 
ACOG Amplitude range 5 bpm or fewer (minimal variability) 
Increased 
variability  
FIGO > 25 bpm 
NICE - 
ACOG Amplitude range greater than 25 bpm (marked variability) 
ACCELERATIONS FIGO Transient increase in heart rate of 15 bpm or more and lasting 15 seconds or more. 
 NICE Transient increases in FHR of 15 bpm or more and lasting 15 seconds or more. 
 ACOG A visually apparent abrupt increase (onset to peak in less than 30 seconds) in the FHR. Beyond 32 weeks of gestation, an acceleration has a peak 
of 15 bpm or more above the baseline, with a duration of 15 seconds or more but less than 2 minutes from onset to return. Prolonged accelerations 
last 2 minutes or more but less than 10 minutes.  
DECELERATIONS FIGO Transient episodes of slowing of FHR below the baseline level of more than 15 bpm and lasting 10 seconds or more. 
 NICE Transient episodes of slowing of FHR below the baseline level of more than 15 bpm and lasting 15 seconds or more. 
 ACOG - 
Early decelerations FIGO - 
NICE Uniform, repetitive, periodic slowing of FHR with onset early in the contraction and return to baseline at the end of the contraction. 
ACOG Visually apparent usually symmetrical gradual decrease and return of the FHR associated with a uterine contraction. A gradual decrease is 
defined as from the onset to the FHR nadir of 30 seconds or more. The decrease in FHR is calculated from the onset to the nadir of the 
deceleration. The nadir of the deceleration occurs at the same time as the peak of the contraction. In most cases, the onset, nadir, and recovery of 
the deceleration are coincident with the beginning, peak, and ending of the contraction, respectively. 
Late decelerations FIGO - 
NICE Uniform, repetitive, periodic slowing of FHR with onset mid to end of the contraction and nadir more than 20 seconds after the peak of the 
contraction and ending after the contraction. In the presence of a non-accelerative trace with baseline variability less than 5 bpm, the definition 
would include decelerations less than 15 bpm  
ACOG Visually apparent usually symmetrical gradual decrease and return of the FHR associated with a uterine contraction. A gradual decrease is 
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defined as from the onset to the FHR nadir of 30 seconds or more. The decrease in FHR is calculated from the onset to the nadir of the 
deceleration. The deceleration is delayed in timing, with the nadir of the deceleration occurring after the peak of the contraction. In most cases, 
the onset, nadir, and recovery of the deceleration occur after the beginning, peak, and ending of the contraction, respectively. 
Variable 
decelerations 
FIGO - 
NICE Variable, intermittent periodic slowing of FHR with rapid onset and recovery. Time relationships with contraction cycle are variable and they 
may occur in isolation. Sometimes they resemble other types of deceleration patterns in timing and shape*. 
ACOG Visually apparent abrupt decrease in FHR. An abrupt decrease is defined as from the onset of the deceleration to the beginning of the FHR nadir 
of less than 30 seconds. The decrease in FHR is calculated from the onset to the nadir of the deceleration. The decrease in FHR is 15 bpm or 
greater, lasting 15 seconds or greater, and less than 2 minutes in duration. When variable decelerations are associated with uterine contractions, 
their onset, depth, and duration commonly vary with successive uterine contractions. 
Prolonged 
decelerations 
FIGO - 
NICE An abrupt decrease in FHR to levels below the baseline that lasts at least 60-90 seconds. These decelerations become pathological if they cross 
two contractions (i.e. greater than 3 minutes) 
ACOG Visually apparent decrease in the FHR below the baseline. Decrease in FHR from the baseline that is 15 bpm or more, lasting 2 minutes or more 
but less than 10 minutes in duration. If a deceleration lasts 10 minutes or longer, it is a baseline change.   
SINUSOIDAL 
PATTERN 
FIGO Regular cyclic changes in the FHR baseline, such as the sine wave. The characteristics of the pattern being: the frequency is less than 6 
cycles/min, the amplitude is at least 10 bpm and the duration should be 20 minutes or longer. 
 NICE A regular oscillation of the baseline long-term variability resembling a sine wave. This smooth, undulating pattern, lasting at least 10 minutes, has 
a relatively fixed period of 3-5 cycles per minute and an amplitude of 5-15 bpm above and below the baseline. Baseline variability is absent. 
 ACOG Visually apparent, smooth, sine wave-like undulating pattern in FHR baseline with a cycle frequency of 3-5 per minute which persists for 20 
minutes or more. 
 
*The NICE guidelines also define “atypical variable decelerations” when the following additional components are found: 
loss of primary or secondary rise in baseline rate, slow return to baseline FHR after the end of a contraction, prolonged 
secondary rise in baseline rate, byphasic deceleration, loss of variability during deceleration, continuation of baseline rate at 
lower level. Bpm, beats per minute. Adapted from Ayres-de-Campos D, Bernardes J. Twenty-five years after the FIGO 
guidelines for the use of fetal monitoring: time for a simplified approach? Int J Gynaecol Obstet. 2010;110(1):1–6. 
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Table 2. Comparison of cardiotocography (CTG) classification criteria in the FIGO, NICE and ACOG 
guidelines. 
FIGO  NICE ACOG 
NORMAL PATTERN 
 
- Baseline heart rate between 110 and 150 
bpm 
- Amplitude of heart rate variability between 
5 and 25 bpm 
 
NORMAL  (a CTG where all of the 
following four reassuring features are 
present) 
 
- Baseline rate: 110-160 bpm 
- Variability: ≥5 bpm 
- No decelerations 
- Accelerations: present 
CATEGORY I (category I FHR tracings include 
all of the following) 
 
- Baseline rate: 110-160 bpm 
- Baseline variability: 6-25 bpm 
- Late or variable decelerations: absent 
- Early decelerations: present or absent 
- Accelerations: present or absent 
 
SUSPICIOUS PATTERN 
 
- Baseline heart rate between 150 and 170 
bpm or between 100 and 110 bpm 
- Amplitude of variability between 5 and 10 
bpm for more than 40 minutes 
- Increased variability above 25 bpm 
- Variable decelerations 
 
SUSPICIOUS (a CTG where one of 
the following features is present and all 
others fall into the reassuring category)  
 
- Baseline rate 
     100-109 bpm  
     161-180 bpm 
- Baseline variability 
     < 5 bpm for 40-90 minutes 
- Decelerations 
     Typical variable decelerations with 
over 50% of contractions occurring 
for over 90 minutes 
     Single prolonged deceleration for up 
to 3 minutes 
- Accelerations 
     The absence of accelerations with an 
otherwise normal trace is of 
uncertain significance 
      
CATEGORY II (Category II FHR tracings 
include all FHR tracings not categorised as Category I 
or Category III. Examples of Category II FHR tracings 
include any of the following)  
 
- Baseline rate 
     Bradycardia not accompanied by absent baseline 
variability  
     Tachycardia 
- Baseline variability 
     Minimal variability 
     Absent variability with no recurrent decelerations 
     Marked variability 
- Accelerations 
     Absence of induced accelerations after fetal 
stimulation 
 - Periodic or episodic decelerations 
     Recurrent variable decelerations accompanied by 
minimal or moderate baseline variability 
     Prolonged deceleration 2-10 minutes 
     Recurrent late decelerations with moderate baseline 
variability 
     Variable decelerations with other characteristics 
such as slow return to baseline, overshoots or 
shoulders 
 
PATHOLOGICAL PATTERN 
 
- Baseline heart rate below 100 or above 170 
bpm 
- Persistence of heart rate variability of less 
than 5 bpm for more than 40 minutes 
- Severe variable decelerations or severe 
repetitive early decelerations. 
- Prolonged decelerations 
- Late decelerations: the most ominous trace 
is a steady baseline without baseline 
PATHOLOGICAL (a CTG with 
one or more of the following features or 
two or more features in the previous 
category)  
 
- Baseline rate 
     < 100 bpm  
     > 180 bpm 
     Sinusoidal pattern ≥ 10 minutes 
- Baseline variability 
     < 5 bpm for ≥ 90 minutes 
CATEGORY III (Category III FHR tracings 
include either) 
 
- Absent baseline FHR variability and any of the 
following: 
     Recurrent late decelerations 
     Recurrent variable decelerations 
     Bradycardia 
- Sinusoidal pattern 
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variability and with small decelerations after 
each contraction 
- A sinusoidal pattern 
 
- Decelerations 
     atypical variable decelerations with 
over 50% contractions for > 30 
minutes 
     Late decelerations for > 30 minutes 
     Prolonged deceleration > 3 minutes 
 
 
FIGO, International Federation of Gynecology and Obstetrics; ACOG, the American College of Obstetricians and Gynecologists, NICE, 
National Institute of Clinical Excellence; FHR, fetal heart rate; bpm, beats per minute.  
Adapted from Ayres-de-Campos D, Bernardes J. Twenty-five years after the FIGO guidelines for the use of fetal monitoring: time for a 
simplified approach? Int J Gynaecol Obstet. 2010;110(1):1–6. 
 
 
Table 3. Distribution of the different evaluations of basic cardiotocography (CTG) features and overall tracing 
classification by the three groups of clinicians, using the FIGO, ACOG and NICE guidelines respectively, n = 
number of ratings, % = percentage of tracings where these ratings were attributed. Total number of CTG 
evaluations for each study group was 1359 (151 x 9 clinicians). 
 
CTG features  FIGO 1987 ACOG 2010 NICE 2007 
  n  % n % n % 
Normal  Normal 848 62 1120 82 1079 79 
 Tachycardia 443 33 195 14 251 19 
 Bradycardia 68 5 44 3 29 2 
        
Variability Normal 1066 78 1127 83 1157 85 
 Abnormal 293 22 232 17 202 15 
        
Accelerations  Present 816 60 805 59 529 39 
 Absent 543 40 554 41 830 61 
        
Decelerations –  Present 1228 90 1205 89 1207 89 
 Absent 131 10 154 11 152 11 
Overall tracing 
classification 
       
   Cat. I /Normal 116 9  171 13 401 30 
   Cat. II /Suspicious 712 52  1106 81 452 33 
 Cat. III /Pathological 531 39  82 6  506 37 
 
FIGO, International Federation of Gynecology and Obstetrics; ACOG, the American College of Obstetricians and Gynecologists, NICE, 
National Institute of Clinical Excellence. 
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Table 4. Interobserver agreement evaluated by the proportions of agreement (PA), and reliability evaluated by the kappa statistics (k) with respective 95% 
confidence intervals (95% CI), for the evaluation of basic cardiotocography (CTG) features and overall tracing classification by the three study groups of 
clinicians. 
  
 FIGO 1987 ACOG 2010 NICE 2007 
 PA (95% CI) k (95% CI) PA (95% CI) k (95% CI) PA (95% CI) k (95% CI) 
FHR baseline 0.81 (0.78-0.85) 0.63 (0.57-0.70) 0.88 (0.84-0.91) 0.59 (0.49-0.69) 0.88 (0.85-0.91) 0.65 (0.58-0.72) 
  Normal 0.86 (0.83-0.89)  0.93 (0.90-0.95)  0.93 (0.91-0.96)  
  Tachycardia 0.80 (0.73-0.85)  0.67 (0.57-0.77)  0.73 (0.66-0.80)  
  Bradycardia 0.40 (0.25-0.54)  0.49 (0.07-0.71)  0.42 (0.00-1.00)  
Variability 0.83 (0.80-0.86) 0.51 (0.42-0.61) 0.85 (0.82-0.88) 0.49 (0.39-0.59) 0.83 (0.80-0.86) 0.38 (0.29-0.50) 
  Normal 0.89 (0.87-0.92)  0.91 (0.89-0.93)  0.90 (0.88-0.92)  
  Abnormal 0.61 (0.51-0.69)  0.57 (0.45-0.66)  0.44 (0.32-0.53)  
Accelerations  0.67 (0.64-0.71) 0.34 (0.29-0.41) 0.67 (0.63-0.70) 0.34 (0.28-0.40) 0.71 (0.68-0.75) 0.41 (0.35-0.48) 
  Yes 0.73 (0.68-0.77)  0.72 (0.67-0.76)  0.61 (0.57-0.68)  
  No 0.59 (0.54-0.64)  0.59 (0.53-0.64)  0.76 (0.72-0.80)  
Decelerations 0.92 (0.89-0.95) 0.53 (0.43-0.66) 0.85 (0.82-0.88) 0.28 (0.18-0.46) 0.89 (0.85-0.91) 0.47 (0.35-0.59) 
  Yes 0.96 (0.94-0.97)  0.92 (0.89-0.93)  0.94 (0.92-0.95)  
  No 0.59 (0.48-0.69)  0.35 (0.23-0.45)  0.49 (0.36-0.59)  
Classification 0.64 (0.61-0.67) 0.37 (0.31-0.43) 0.73 (0.70-0.76) 0.15 (0.10-0.21) 0.55 (0.51-0.58) 0.33 (0.28-0.39) 
  Cat. I /Normal 0.54 (0.39-0.64)  0.26 (0.18-0.33)  0.55 (0.48-0.62)  
  Cat. II /Suspicious 0.67 (0.62-0.70)  0.83 (0.81-0.86)  0.42 (0.38-0.47)  
  Cat. III /Pathological 0.63 (0.57-0.68)  0.26 (0.18-0.34)  0.66 (0.59-0.71)  
 
FHR, fetal heart rate; FIGO, International Federation of Gynecology and Obstetrics; ACOG, the American College of Obstetricians and Gynecologists, NICE, National Institute of Clinical Excellence. 
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Table 5. Interobserver agreement evaluated by the proportions of agreement (PA) with respective 95% 
confidence intervals (95% CI), for tracing classification by clinicians of the three study groups, according to 
their previous experience in cardiotocography interpretation. 
 
 FIGO 1987 ACOG 2010 NICE 2007 
  PA (95% CI) PA (95% CI) PA 95% CI 
> 10 years experience    
Overall 0.61 (0.56-0.67) 0.58 (0.53-0.63) 0.54 (0.48-0.59) 
Cat. I/ Normal 0.52 (0.31-0.68) 0.31 (0.20-0.40) 0.60 (0.52-0.68) 
Cat. II/ Suspicious 0.67 (0.60-0.72) 0.70 (0.65-0.74) 0.33 (0.25-0.41) 
Cat. III/ Pathological 0.56 (0.47-0.64) 0.32 (0.13-0.48) 0.66 (0.57-0.74) 
6-10 years experience    
Overall        0.62 (0.58-0.68) 0.73 (0.68-0.79) 0.54 (0.49-0.60) 
Cat. I/ Normal 0.57 (0.38-0.71) 0.11 (0.03-0.19) 0.48 (0.33-0.60) 
Cat. II/ Suspicious 0.65 (0.59-0.71) 0.84 (0.80-0.88) 0.44 (0.36-0.52) 
Cat. III/ Pathological 0.60 (0.51-0.68) 0.12 (0.00-0.21) 0.65 (0.58-0.72) 
< 6 years experience    
Overall       0.63 (0.58-0.69) 0.88 (0.85-0.92) 0.55 (0.49-0.60) 
Cat. I/ Normal 0.52 (0.29-0.69) 0.46 (0.25-0.64) 0.58 (0.48-0.68) 
Cat. II/ Suspicious 0.63 (0.57-0.70) 0.94 (0.91-0.96) 0.39 (0.32-0.46) 
Cat. III/ Pathological 0.65 (0.58-0.73) 0.25 (0.00-0.53) 0.67 (0.57-0.74) 
 
FIGO, International Federation of Gynecology and Obstetrics; ACOG, the American College of Obstetricians and Gynecologists, NICE, 
National Institute of Clinical Excellence. 
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Table 6. Sensitivity and specificity of all tracings classified by observers as pathological or category III in 
prediction of newborn acidemia, by study group, and according to the number of years of experience of the 
clinicians in cardiotocography analysis (95% CI= 95% confidence intervals). 
 
 Sensitivity % (95% CI) Specificity % (95% CI) 
FIGO 1987 89 (52-98) 63 (55-71) 
   > 10 years experience 90 (59-100) 67 (59-74) 
   6-10 years experience 86 (42-100) 64 (56-72) 
   < 6 years experience 90 (59-100) 58 (50-66) 
ACOG 2010 32 (10-67) 95 (90-98) 
   > 10 years experience 38 (10-71) 92 (87-96) 
   6-10 years experience 24 (4-58) 95 (91-98) 
   < 6 years experience 33 (18-81) 98 (94-99) 
NICE 2007 97 (61-100) 66 (58-73) 
   > 10 years experience 95 (56-100) 72 (64-79) 
   6-10 years experience 95 (59-100) 57 (49-65) 
   < 6 years experience 
 
100 (59-100) 67 (59-75) 
 
 
FIGO, International Federation of Gynecology and Obstetrics; ACOG, the American College of Obstetricians and Gynecologists, NICE, 
National Institute of Clinical Excellence. 
 
 
 
 
 
 
 
